Медицинская литература. Новинки

 

 

 

 

 

 

Практические рекомендации ISUOG (переработанные и дополненные): ультразвуковое скрининговое исследование сердца плода

Вы можете загрузить полный текст статьи в формате pdf

Ключевые слова:

Литература:
1.Cardiac screening examination of the fetus: guidelines for performing the ’basic’ and ’extended basic’ cardiac scan. Ultrasound Obstet Gynecol 2006; 27: 107-113.
2.Antenatal care: routine care for the healthy pregnant woman. http://www.nice.org.uk/CG062 [Accessed 23 October 2011].
3.18 + 0 to 20 + 6 weeks fetal anomaly scan - National standards and guidance for England 2010. http:// fetalanomaly.screening.nhs.uk/standardsandpolicies2010 [Accessed 26 November 2011].
4.Ultrasound Screening: Supplement to Ultrasound Screening for Fetal Abnormalities. http://www. rcog.org.uk/print/womens-health/clinical-guidance/ultrasound-screeningRCOG2011 [Accessed 27 November 2011].
5.Israel Society of Ultrasound in Obstetrics and Gynecology. http://www.isuog.org.il/main/site-New/Ppage=&action=sidLink&stld=301 [Accessed 6 February 2012].
6.Ferencz C., Rubin J.D., McCarter R.J., Brenner J.I., Neill C.A., Perry L.W., Hepner S.I., Downing J.W. Congenital heart disease: prevalence at live birth. The Baltimore-Washington Infant Study. Am J Epidemiol 1985; 121: 31-36.
7.Meberg A., Otterstad J.E., Froland G., Lindberg H., Sorland S.J. Outcome of congenital heart defects - a population-based study. Acta Paediatr 2000; 89:1344-1351.
8.Cuneo B.F., Curran L.F., Davis N., Elrad H. Trends in prenatal diagnosis of critical cardiac defects in an integrated obstetric and pediatric cardiac imaging center. J Perinatol 2004; 24: 674-678.
9.Rosano A., Botto L.D., Botting B., Mastroiacovo P. Infant mortality and congenital anomalies from 1950 to 1994: an international perspective. J Epidemiol Community Health 2000; 54: 660-666.
10.Crane J.P., LeFevre M.L., Winborn R.C., Evans J.K., Ewigman B.G., Bain R.P., Frigoletto F.D., McNellis D. A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. The RADIUS Study Group. Am J Obstet Gynecol 1994; 171: 392-399.
11.Abu-Harb M., Hey E., Wren C. Death in infancy from unrecognised congenital heart disease. Arch Dis Child 1994; 71: 3-7.
12.Bonnet D., Coltri A., Butera G., Fermont L., Le Bidois J., Kachaner J., Sidi D. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999; 99: 916-918.
13.Tworetzky W., McElhinney D.B., Reddy V.M., Brook M.M., Hanley F.L., Silverman N.H. Improved surgical outcome after fetal diagnosis ofhypoplastic left heart syndrome. Circulation 2001; 103: 1269-1273.
14.Andrews R., Tulloh R., Sharland G., Simpson J., Rollings S., Baker E., Qureshi S., Rosenthal E., Austin C., Anderson D. Outcome of staged reconstructive surgery for hypoplastic left heart syndrome following antenatal diagnosis. Arch Dis Child 2001; 85: 474-477.
15.Franklin O., Burch M., Manning N., Sleeman K., Gould S., Archer N. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 2002; 87: 67-69.
16.Tworetzky W., Wilkins-Haug L., Jennings R.W., Van Der Velde M.E., Marshall A.C., Marx G.R., Colan S.D., Benson C.B., Lock J.E., Perry S.B. Balloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome: candidate selection, technique, and results of successful intervention. Circulation 2004; 110: 2125-2131.
17.Simpson L.L. Screening for congenital heart disease. Obstet Gynecol Clin North Am 2004; 31: 51-59.
18.DeVore G.R., Medearis A.L., Bear M.B., Horenstein J., Platt L.D. Fetal echocardiography: factors that inluence imaging of the fetal heart during the second trimester of pregnancy. J Ultrasound Med 1993; 12: 659-663.
19.Sharland G.K., Allan L.D. Screening for congenital heart disease prenatally. Results of a 2,5-year study in the South East Thames Region. Br J Obstet Gynaecol 1992; 99: 220-225.
20.Carvalho J.S., Mavrides E., Shinebourne E.A., Campbell S., Thilaganathan B. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 2002; 88: 387-391.
21.Hunter S., Heads A., Wyllie J., Robson S. Prenatal diagnosis of congenital heart disease in the northern region of England: benefits of a training programme for obstetric ultrasonographers. Heart 2000; 84: 294-298.
22.Lee W. Performance of the basic fetal cardiac ultrasound examination. J Ultrasound Med 1998; 17: 601-607.
23.AIUM. AIUM Practice Guideline for the performance of an antepartum obstetric ultrasound examination. J Ultrasound Med 2003; 22: 1116-1125.
24.ACR Practice Guideline for the performance of antepartum obstetrical ultrasound. Am Coll Radiol 2003: 689-695.
25.ACOG Practice Bulletin No. 58. Ultrasonography in pregnancy. Obstet Gynecol 2004; 104: 1449-1458.
26.Lee W., Allan L., Carvalho J.S., Chaoui R., Copel J., Devore G., Hecher K., Munoz H., Nelson T., Paladini D., Yagel S. ISUOG Fetal Echocardiography Task Force. ISUOG consensus statement: what constitutes a fetal echocardiogram? Ultrasound Obstet Gynecol 2008; 32: 239-242.
27.Tegnander E., Eik-Nes S.H., Johansen O.J., Linker D.T. Prenatal detection of heart defects at the routine fetal examination at 18 weeks in a non-selected population. Ultrasound Obstet Gynecol 1995; 5: 372-380.
28.Chaoui R. The four-chamber view: four reasons why it seems to fail in screening for cardiac abnormalities and suggestions to improve detection rate. Ultrasound Obstet Gynecol 2003; 22: 3-10.
29.Tegnander E., Eik-Nes S.H., Linker D.T. Incorporating the four-chamber view of the fetal heart into the second-trimester routine fetal examination. Ultrasound Obstet Gynecol 1994; 4: 24-28.
30.Achiron R., Rotstein Z., Lipitz S., Mashiach S., Hegesh J. First-trimesagnosis of fter dietal congenital heart disease by transvaginal ultrasonography. Obstet Gynecol 1994; 84: 69-72.
31.Yagel S., Weissman A., Rotstein Z., Manor M., Hegesh J., Anteby E., Lipitz S., Achiron R. Congenital heart defects: natural course and in utero development. Circulation 1997; 96: 550-555.
32.Rustico M.A., Benettoni A., D’Ottavio G., Fischer-Tamaro L., Conoscenti G.C., Meir Y., Natale R., Bussani R., Mandruzzato G.P. Early screening for fetal cardiac anomalies by transvaginal echocardiography in an unselected population: the role of operator experience. Ultrasound Obstet Gynecol 2000; 16: 614-619.
33.Carvalho J.S. Fetal heart scanning in the first trimester. Prenat Diagn 2004; 24: 1060-1067.
34.Carvalho J.S., Moscoso G., Tekay A., Campbell S., Thilaganathan B., Shinebourne E.A. Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies. Heart 2004; 90: 921-926.
35.Huggon I.C., Ghi T., Cook A.C., Zosmer N., Allan L.D., Nicolaides K.H. Fetal cardiac abnormalities identified prior to 14 weeks’ gestation. Ultrasound Obstet Gynecol 2002; 20: 22-29.
36.Schwarzler P., Senat M.V., Holden D., Bernard J.P., Masroor T., Ville Y. Feasibility of the second-trimester fetal ultrasound examination in an unselected population at 18, 20 or 22 weeks of pregnancy: a randomized trial. Ultrasound Obstet Gynecol 1999; 14: 92-97.
37.Paladini D., Vassallo M., Tartaglione A., Lapadula C., Martinelli P. The role of tissue harmonic imaging in fetal echocardiography. Ultrasound Obstet Gynecol 2004; 23: 159-164.
38.Allan L.D., Crawford D.C., Chita S.K., Tynan M.J. Prenatal screening for congenital heart disease. Br Med J (Clin Res Ed) 1986; 292: 1717-1719.
39.Copel J.A., Pilu G., Green J., Hobbins J.C., Kleinman C.S. Fetal echocardiographic screening for congenital heart disease: the importance of the four-chamber view. Am J Obstet Gynecol 1987; 157: 648-655.
40.Kirk J.S., Riggs T.W., Comstock C.H., Lee W., Yang S.S., Weinhouse E. Prenatal screening for cardiac anomalies: the value ofroutine addition of the aortic root to the four-chamber view. Obstet Gynecol 1994; 84:427-431.
41.DeVore G.R. The aortic and pulmonary outlow tract screening examination in the human fetus. J Ultrasound Med 1992; 11: 345-348.
42.Achiron R., Glaser J., Gelernter I., Hegesh J., Yagel S. Extended fetal echocardiographic examination for detecting cardiac malformations in low risk pregnancies. BMJ 1992; 304: 671-674.
43.Achiron R., Rotstein Z., Heggesh J., Bronshtein M., Zimand S., Lipitz S., Yagel S. Anomalies of the fetal aortic arch: a novel sonographic approach to inutero diagnosis. Ultrasound Obstet Gynecol 2002; 20: 553-557.
44.Yoo S.J., Min J.Y., Lee Y.H., Roman K., Jaeggi E., Smallhorn J. Fetal sonographic diagnosis of aortic arch anomalies. Ultrasound Obstet Gynecol 2003; 22: 535-546.
45.Barboza J.M., Dajani N.K., Glenn L.G., Angtuaco T.L. Prenatal diagnosis of congenital cardiac anomalies: a practical approach using two basic views. Radiographics 2002; 22: 1125-1137; discussion 1137-1138.
46.Del Bianco A., Russo S., Lacerenza N., Rinaldi M., Rinaldi G., Nappi L., Greco P. Four chamber view plus three-vessel and trachea view for a complete evaluation of the fetal heart during the second trimester. J Perinat Med 2006; 34: 309-312.
47.Di Salvo D.N., Brown D.L., Doubilet P.M., Benson C.B., Frates M.C. Clinical signiicance of isolated fetal pericardial effusion. J Ultrasound Med 1994; 13: 291-293.
48.Yoo S.J., Min J.Y., Lee Y.H. Normal pericardial fluid in the fetus: color and spectral Doppler analysis. Ultrasound Obstet Gynecol 2001; 18: 248-252.
49.Comstock C.H. Normal fetal heart axis and position. Obstet Gynecol 1987; 70: 255-259.
50.Smith R.S., Comstock C.H., Kirk J.S., Lee W. Ultrasonographic left cardiac axis deviation: a marker for fetal anomalies. Obstet Gynecol 1995; 85: 187-191.
51.ACOG Practice Bulletin No. 106: Intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management principles. Obstet Gynecol 2009; 114: 192-202.
52.Copel J.A., Liang R.I., Demasio K., Ozeren S., Kleinman C.S. The clinical signiicance of the irregular fetal heart rhythm. Am J Obstet Gynecol 2000; 182: 813-817.
53.Simpson J.L., Yates R.W., Sharland G.K. Irregular heart rate in the fetus: not always benign. Cardiol Young 1996; 6: 28-31.
54.Cuneo B.F., Strasburger J.F., Wakai R.T., Ovadia M. Conduction system disease in fetuses evaluated for irregular cardiac rhythm. Fetal Diagn Ther 2006; 21:307-313.
55.Srinivasan S., Strasburger J. Overview of fetal arrhythmias. Curr Opin Pediatr 2008; 20: 522-531.
56.Kirk J.S., Comstock C.H., Lee W., Smith R.S., Riggs T.W., Weinhouse E. Fetal cardiac asymmetry: a marker for congenital heart disease. Obstet Gynecol 1999; 93:189-192.
57.Sharland G.K., Chan K.Y., Allan L.D. Coarctation of the aorta: difficulties in prenatal diagnosis. Br Heart J 1994; 71: 70-75.
58.Hornberger L.K., Sanders S.P., Rein A.J., Spevak P.J., Parness I.A., Colan S.D. Left heart obstructive lesions and left ventricular growth in the midtrimester fetus. A longitudinal study. Circulation 1995; 92:1531-1538.
59.Paladini D., Palmieri S., Lamberti A., Teodoro A., Martinelli P., Nappi C. Characterization and natural history of ventricular septal defects in the fetus. Ultrasound Obstet Gynecol 2000; 16: 118-122.
60.Axt-Fliedner R., Schwarze A., Smrcek J., Germer U., Krapp M., Gembruch U. Isolated ventricular septal defects detected by color Doppler imaging: evolution during fetal and first year of postnatal life. Ultrasound Obstet Gynecol 2006; 27: 266-273.
61.Vettraino I.M., Lee W., Bronsteen R.A., Comstock C.H. Sonographic evaluation of the ventricular cardiac outlow tracts. J Ultrasound Med 2005; 24: 566.
62.Bromley B., Estroff J.A., Sanders S.P., Parad R., Roberts D., Frigoletto F.D., Jr., Benacerraf BR. Fetal echocardiography: accuracy and limitations in a population at high and low risk for heart defects. Am J Obstet Gynecol 1992; 166: 1473-1481.
63.Stumplen I., Stumplen A., Wimmer M., Bernaschek G. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet 1996; 348: 854-857.
64.Yoo S.J., Lee Y.H., Kim E.S., Ryu H.M., Kim M.Y., Choi H.K., Cho K.S., Kim A. Three-vessel view of the fetal upper mediastinum: an easy means of detecting abnormalities of the ventricular outlow tracts and great arteries during obstetric screening. Ultrasound Obstet Gynecol 1997; 9: 173-182.
65.Yoo S.J., Lee Y.H., Cho K.S. Abnormal three-vessel view on sonography: a clue to the diagnosis of congenital heart disease in the fetus. AJR Am J Roentgenol 1999; 172: 825-830.
66.Vinals F., Heredia F., Giuliano A. The role of the three vessels and trachea view (3VT) in the diagnosis of congenital heart defects. Ultrasound Obstet Gynecol 2003; 22: 358-367.
67.Yagel S., Arbel R., Anteby E.Y., Raveh D., Achiron R. The three vessels and trachea view (3VT) in fetal cardiac scanning. Ultrasound Obstet Gynecol 2002; 20: 340-345.
68.Tongsong T., Tongprasert F., Srisupundit K., Luewan S. The complete three-vessel view in prenatal detection of congenital heart defects. Prenat Diagn 2010; 30: 23-29.
69.Berg C., Gembruch U., Geipel A. Outlow tract views in two-dimensional fetal echocardiography - part ii. Ultraschall Med 2009; 30: 230-251.
70.Yagel S., Cohen S.M., Achiron R. Examination of the fetal heart by ive short-axis views: a proposed screening method for comprehensive cardiac evaluation. Ultrasound Obstet Gynecol 2001; 17: 367-369.
71.Chaoui R., McEwing R. Three cross-sectional planes for fetal color Doppler echocardiography. Ultrasound Obstet Gynecol 2003; 21: 81-93.
72.Paladini D. Sonography in obese and overweight pregnant women: clinical, medicolegal and technical issues. Ultrasound Obstet Gynecol 2009; 33: 720-729.
73.Nadel A.S. Addition of color Doppler to the routine obstetric sonographic survey aids in the detection of pulmonic stenosis. Fetal Diagn Ther 2010; 28: 175-179.
74.Small M., Copel J.A. Indications for fetal echocardiography. Pediatr Cardiol 2004; 25: 210-222.
75.Hyett J., Moscoso G., Papapanagiotou G., Perdu M., Nicolaides K.H. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks ofgestation. Ultrasound Obstet Gynecol 1996; 7: 245-250.
76.Hyett J.A., Perdu M., Sharland G.K., Snijders R.S., Nicolaides K.H. Increased nuchal translucency at 10-14 weeks ofgestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 1997; 10: 242-246.
77.Mavrides E., Cobian-Sanchez F., Tekay A., Moscoso G., Campbell S., Thilaganathan B., Carvalho J.S. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001;17:106-110.
78.Ghi T., Huggon I.C., Zosmer N., Nicolaides K.H. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 2001; 18: 610-614.
79.Paladini D., Volpe P., Sglavo G., Vassallo M., De Robertis V., Marasini M., Russo M.G. Transposition of the great arteries in the fetus: assessment of the spatial relationships of the arterial trunks by fourdimensional echocardiography. Ultrasound Obstet Gynecol 2008; 31: 271-276.
80.Volpe P., Campobasso G., De Robertis V., Di Paolo S., Caruso G., Stanziano A. Volpe N., Gentile M. Two- and four-dimensional echocardiography with B-flow imaging and spatiotemporal image correlation in prenatal diagnosis of isolated total anomalous pulmonary venous connection. Ultrasound Obstet Gynecol 2007; 30: 830-837.
81.Volpe P., Tuo G., De Robertis V., Campobasso G., Marasini M., Tempesta A., Gentile M., Rembouskos G. Fetal interrupted aortic arch: 2D-4D echocardiography, associations and outcome. Ultrasound Obstet Gynecol 2010; 35: 302-309.

ISUOG Practice Guidelines (Updated): Sonographic Screening Examination of the Fetal Heart

Keywords: